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Abstract
Background: The HIV Rev protein is known to facilitate export of incompletely spliced and
unspliced viral transcripts to the cytoplasm, a necessary step in virus life cycle. The Rev-mediated
nucleo-cytoplasmic transport of nascent viral transcripts, dependents on interaction of Rev with
the RRE RNA structural element present in the target RNAs. The C-terminal variant of dsRNA-
binding nuclear protein 90 (NF90ctv) has been shown to markedly attenuate viral replication in
stably transduced HIV-1 target cell line. Here we examined a mechanism of interference of viral life
cycle involving Rev-NF90ctv interaction.
Results:  Since Rev:RRE complex formations depend on protein:RNA and protein:protein
interactions, we investigated whether the expression of NF90ctv might interfere with Rev-
mediated export of RRE-containing transcripts. When HeLa cells expressed both NF90ctv and Rev
protein, we observed that NF90ctv inhibited the Rev-mediated RNA transport. In particular, three
regions of NF90ctv protein are involved in blocking Rev function. Moreover, interaction of NF90ctv
with the RRE RNA resulted in the expression of a reporter protein coding sequences linked to the
RRE structure. Moreover, Rev influenced the subcellular localization of NF90ctv, and this process
is leptomycin B sensitive.
Conclusion: The dsRNA binding protein, NF90ctv competes with HIV Rev function at two levels,
by competitive protein:protein interaction involving Rev binding to specific domains of NF90ctv, as
well as by its binding to the RRE-RNA structure. Our results are consistent with a model of Rev-
mediated HIV-1 RNA export that envisions Rev-multimerization, a process interrupted by
NF90ctv.
Background
Upon entering an uninfected host cell, the single-stranded
RNA genome of Human immunodeficiency virus type 1
(HIV-1) is copied into DNA by the viral reverse tran-
scriptase. Following integration of DNA into the host
genome, transcriptional activation of the proviral DNA
generates progeny virions. The post-integration events of
transcription, RNA splicing, transport and translation of
Published: 24 November 2006
Retrovirology 2006, 3:83 doi:10.1186/1742-4690-3-83
Received: 01 September 2006
Accepted: 24 November 2006
This article is available from: http://www.retrovirology.com/content/3/1/83
© 2006 Urcuqui-Inchima et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
Page 2 of 13
(page number not for citation purposes)
viral mRNAs are regulated by coordinate interaction with
host proteins [1]. Strict dependence of viral gene expres-
sion on host factors particularly those with protein:RNA
and protein:protein binding properties, are useful targets
to explore novel antiviral therapy.
Regulation of HIV-1 gene expression is controlled mainly
by the two virus encoded proteins, Tat responsible for
processive transcription elongation, and Rev which regu-
lates transport of unspliced and incompletely spliced viral
transcripts from the nucleus to the cytoplasm. These two
regulatory proteins function by binding to structured RNA
domains present in the viral transcripts, the trans-activa-
tion responsive RNA (TAR) and the Rev response element
(RRE) respectively.
The functional domains of Rev include an N-terminal
nuclear localization signal (NLS) rich in Arg-residues, and
a C-terminal nuclear export signal (NES) rich in Leu-resi-
dues. The NES of Rev interacts with host proteins that are
critical for RNA export, and the NLS binds to the RRE-RNA
structure, and is also involved in Rev-homodimerization
[2-4]. After dissociation from RRE in the cytoplasm, the
NLS of Rev binds to importin-β (Imp-β), allowing its
import back into the nucleus. Once in the nucleus, Rev
interacts with the RRE RNA present in the incompletely
spliced and unspliced viral transcripts. The newly formed
Rev:RRE complex recruits proteins such as Crm1 [3] or
eIF5A [2] that are essential cofactors in regulating nuclear
export [5,6]. Interaction of Rev with Crm1 occurs via the
NES present in both proteins [7] a process inhibited by
the leptomycin B (LMB). The NES domains play a critical
role in the intracellular localization of viral and cellular
proteins [8-10].
The Rev:RRE:Crm1 complex is translocated through the
nuclear pore complex to the cytoplasm. This translocation
is dependant on the RNA helicase activity of DDX3, which
binds to the Rev:RRE:Crm1 complex on the nuclear side
of the Nuclear Pore Complex and accompanies it through
to the cytoplasmic side [11,12]. After dissociation, the
viral transcripts are recognized by the translation machin-
ery for synthesis of viral structural proteins [2].
In murine fibroblast A9 cells, export of HIV-1 transcripts
mediated by Rev is restricted due to as yet unidentified
host cell factor(s) that block Rev-mediated transport.
However the Rex protein, an analogue of Rev encoded by
the Human T cell leukemia virus type 1 (HTLV-1) is able
to mediate RNA transport in murine cells. Marques et al.
[13] reported that a chimeric protein containing the N-ter-
minal region of Rev (amino acids 1–79) comprising the
NLS, and the C-terminal region of Rex (amino acids 79–
95) comprising the NES region of Rex, restored Rev-medi-
ated RNA transport in A9 cells, suggesting that a putative
murine cell inhibitor of Rev-function might recognize
NES domain of Rev.
NF90 is encoded by the ilf-3 gene, which by alternative
splicing [14,15] gives rise to a family of double stranded
RNA binding domain(DRBD) proteins that include NF90,
NF110, MPP4 90, MPP4 110, ILF-3, NFAR-1 and NFAR-2,
which are implicated in different functions such as tran-
scription, RNA splicing, RNA editing and export. It is
unclear if any of the DRBD proteins directly influence
Rev-dependent RNA transport.
The proteins in this family are characterized by the pres-
ence of two C-terminal dsRNA binding domains (DRBD 1
and DRBD 2; Fig. 1) that allow the protein to bind struc-
tured and duplexed RNAs [16-18]. NF90 has been found
associated with different viral RNAs, such as human
Adeno-associated virus RNAII, the encapsidation signal ε
in Hepatitis B virus RNA, and bovine viral diarrhea virus
RNA [18-20]. Its central NLS domain and its N-terminal
sequence homologous to zinc finger regions interact with
DNA and RNA [21], and a Leu-rich region functions as an
NES [19]. The NES region is similar to the NES consensus
sequence described in HIV-1 Rev.
We studied a unique form of NF90, designated NF90ctv
[22]. The C-terminal variant, NF90ctv is distinct from
other proteins encoded by ilf-3 in that its C-terminal 67
amino acids (Fig. 1) is Arg-Gly-poor (RG-), whereas the
corresponding C-terminal region is Arg-Gly-rich (RG+) in
all the other proteins of this family. NF90 is predomi-
nantly a nuclear protein. In interphase cells however,
about half of the NF90 is tethered in the nucleus by RNA
bound to protein with dsRNA-dinding motif, while in
mitosis NF90 is phosphorylated and translocated to the
cytoplasm, without loss of its affinity for dsRNA [23]. It
has been reported that NF90 in the cytoplasm can stabi-
lize the IL-2 mRNA by binding to its AU-rich elements
[24]. Moreover, its presence in complexes with the 3'
untranslated region (UTR) of Tau mRNA [25] indicates
that NF90 is part of the protein complex that interacts
with the Tau mRNA, and is essential for its exonal translo-
cation. Thus the NF90 family of proteins, due largely to
their dsRNA recognition function, may affect gene expres-
sion by targeted localization of structured RNA molecules.
Among the proteins encoded by the ilf-3  gene, NF90/
NFAR's proteins have been reported to serve as substrate
for PKR [26]. NF90 protein has characteristics analogous
to those of interferon (IFN) type 1 [22] such as the capac-
ity to activate genes involved in defense against viral infec-
tion. NF90 was originally reported to be a transcription
factor, although it does not possess DNA binding
domains [16]. NF90 can negatively or positively regulate
expression of a reporter gene, depending on the viral pro-Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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Schematic representation of (A) pCMV128 (CAT-RRE reporter), and (B) the NF90ctv regions investigated here Figure 1
Schematic representation of (A) pCMV128 (CAT-RRE reporter), and (B) the NF90ctv regions investigated here. (C) The 
NF90ctv domains were cloned into pCI-neo and used in this study. The vertical arrows correspond to the SH3 motifs present 
in RG- region.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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moter used [27]. The report that NF90ctv arrests HIV-1
replication in human osteosarcoma-derived cells [22],
supports the argument that ectopic expression of NF90ctv
results in overall stimulation of IFN response genes.
We reason that the attenuation of HIV-1 replication in
NF90ctv expressing cells may in part be due to the affinity
of NF90ctv protein to the structured RNA molecules
essential in viral life cycle. That is, in addition to general-
ized induction of the innate antiviral response pathway in
NF90ctv-expressing cells [22], the binding properties of
NF90ctv to structured RNAs are likely to interfere with
specific steps of viral life cycle, particularly those that rely
on precise protein:RNA interactions. Thus, the overall
antiviral response of NF90ctv may result from the stimu-
lated innate immunity of the host following virus infec-
tion as well as from the ability of NF90ctv to interfere with
specific steps in the viral life cycle. Here we examined the
protein:protein and protein-dsRNA interaction properties
of NF90ctv that inhibits HIV-1 replication by blocking
Rev function. The results suggest that NF90ctv negatively
affects the export of HIV-1 transcripts regulated by Rev.
The NF90ctv-mediated inhibition of Rev involved three
specific regions of NF90ctv protein.
Results
NF90ctv inhibits Rev-dependent CAT activity
The CAT-RRE reporter gene (pCMV128; Fig. 1A) was used
to evaluate the export of transcripts that depend on Rev-
RRE interaction. In this reporter system the cytoplasmic
expression of the CAT coding sequence depends on the
presence of functional Rev which allows efficient export of
unspliced and incompletely spliced mRNAs. Rev function
was determined by the level of acetylated chlorampheni-
col expression in HeLa cell extracts. As shown in Figure 2,
CAT activity was absent when the cells were transfected
with the reporter gene alone (lane 1), or with the pCI-neo
empty expression vector (not shown). In the presence of
Rev (pRSV/Rev), there resulted a high level of CAT activity
(lane 2). However, in cells expressing NF90ctv along with
Rev, the CAT activity was greatly reduced (compare lanes
2 and 3) indicating that NF90ctv interfered with the RNA
export activity of Rev.
Next we characterized specific region(s) of NF90ctv (Fig.
1B) implicated in inhibition of Rev function. The 5'- or
the 3'-regions of the NF90ctv coding sequence were
cloned separately into the pCI-neo vector and the result-
ing constructs were used to transfect HeLa cells in the pres-
ence of the reporter pCMV128 and the Rev expression
vector, pRSV/Rev. Both the N-terminal and the C-terminal
regions of NF90ctv inhibited Rev function (Fig. 2, lanes 4
and 5, respectively), suggesting that at least two regions of
NF90ctv contain sequences that affect the Rev function.
As outlined (Fig. 1B), two dsRNA binding motifs (DRBD
1 and DRBD 2) are located in the C-terminal half of
NF90ctv, where as the N-terminal region of NF90ctv may
be involved in protein-protein interactions. By compari-
son with other proteins in the NF90 family, the N-termi-
nal half of NF90ctv contains an NES region (Fig. 1B), and
its C-terminal 67 amino acid sequence is deficient in
arginine/glycine residues (RG-). To evaluate the influence
of specific NF90ctv domains on Rev-dependent CAT activ-
ity, the NES, DRBD 1, DRBD 2 and RG- coding regions
were cloned into the pCI-neo vector (Fig. 1C), and used in
cotransfection experiments in the presence of CAT-RRE
reporter, pCMV128 and the Rev expression vector, pRSV/
Rev. We first verified that the NES, DRBD 2 and RG- frag-
ments without NLS, translocate to the nucleus. Indeed,
when these NF90 protein domains were cloned into the
fluorescent tagged vector, pmRFP and expressed as fusion
proteins, they were observed in the cytoplasm as well as in
the nucleus (data not shown).
As shown in Figure 2, the NES, DRBD 2 and RG- regions
inhibited the Rev dependent CAT activity (lanes 6–8 and
10 respectively); DRBD 1 effect was less pronounced (lane
10); however, RG- showed a higher inhibitory effect on
Rev-mediated RNA export. These results suggest that three
regions of NF90ctv, the NES, DRBD 2 and RG-, are
involved in blocking Rev function, and collectively they
would strongly interfere with Rev function, possibly
involving protein:protein or protein:RNA interactions.
Results similar to those presented in Figure 2 were
obtained with three independent transfection assays with
each of the NF90ctv domains. In control experiments,
using the empty pCI-neo vector, there was no induction of
the CAT reporter gene with or without Rev (data not
shown).
NF90 interact with REV protein
The N-terminus of NF90ctv protein includes a region that
is likely to be involved in protein:protein interactions
[26]. In addition, its C-terminal RG- domain includes
three SH3 motifs (PXXP) that are known to be important
in certain protein:protein interactions [28,29]. Hence a
possible mechanism of NF90ctv-mediated inhibition of
Rev function may include sequestration of Rev involving
NF90ctv:Rev protein interaction. We tested the possibility
by co-expressing Rev and NF90ctv in HeLa cells trans-
fected with pRSV/Rev or pOZ-Flag/NF90. We assessed the
expression of two proteins by Western blotting, using α-
Rev31–50 and anti-FLAG antibodies. Results showed that
both Rev and NF90ctv proteins are expressed in HeLa cells
(data not shown).
To examine NF90ctv:Rev interaction we immunoprecipi-
tated HeLa cell lysates with α-Flag antibodies, 24 hr after
cotransfection with pRSV/Rev and pOZ-Flag/NF90. TheRetrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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resulting protein complex was enriched by addition of
Protein A-agarose beads, resolved by SDS-PAGE and ana-
lyzed by Western blot using the α-Rev31–50 antibodies. The
results show that Rev co-immunoprecipitated with α-Flag
antibodies (Fig. 3, lane 1) in cells that expressed both the
Rev and Flag/NF90 proteins, yielding a band of 28 kDa. In
contrast, Rev was not detected in extracts of HeLa cells that
were not transfected with the Rev-expressing plasmid,
pRSV/Rev (lane 2), or in control assays where cell extracts
were used prior to immunoprecipitation (input cell
extracts; lane 3). The results suggest that Rev specifically
associates with NF90ctv in vivo. As control a 28 kDa band
was observed with the purified Rev protein (Fig. 4B, lane
5). Taken together, the results suggest that interaction
between NF90ctv and Rev proteins could inhibit Rev func-
tion either by sequestration of Rev in NF90ctv:Rev protein
complexes that would lead to a decrease in available Rev
protein for Rev-mediated RRE interaction. Alternatively,
interaction of NF90ctv with another cellular protein(s)
may be involved in blocking Rev export activity.
The RG- region of NF90ctv is involved in interaction with 
Rev
The C-terminal 67 amino acids (604–671) of NF90ctv
designated RG-, possess three SH3 motifs, that appear to
be involved in protein:protein interactions [30]. This
region of NF90ctv was cloned into pGEX-4T-3 leading to
pGST/RG- that is expected to yield a recombinant GST/
RG- protein of ~33 kDa. The protein expressed in E. coli
was purified by affinity chromatography and analyzed by
Western blotting using either a polyclonal α-GST/RG- or
α-GST antibodies. With both types of antibodies, a pro-
tein band migrating at the level of the recombinant GST/
RG- protein was detected. No ~33 kDa band appeared in
similar Western blots with preimmune sera (data not
shown).
The purified GST/RG- protein was used to study the inter-
action of the RG- domain of NF90ctv with Rev. It was cou-
pled to a glutathione-Sepharose 4B column, and used in
pull-down assays by adding extracts from HeLa cells that
express Rev, or with purified Rev protein. After washing to
remove unbound proteins, possible Rev:RG- complexes
were eluted, resolved by SDS-PAGE and visualized by
Coomassie blue staining. As shown in Figure 4 lane 4,
when extract from HeLa cells expressing Rev was added to
the glutathione-Sepharose column, an additional band of
~25 kDa corresponding to Rev protein was detected. This
band was absent from control samples, i.e. lysates from
IPTG-induced E. coli cells (lane 1), or from uninduced
(lane 2) E. coli cells or with extracts from untransfected
HeLa cells (lane 3). Similar results were obtained when
purified Rev expressed in E. coli replaced the HeLa cell
extracts previously transfected with pRSV/Rev (lane 5). It
should be noted that in all cases a double band of about
33 kDa was observed for GST/RG- but only the faster-
migrating band was recognized by the α-GST/RG- or α-
GST (Amersham) antibodies. The results indicate that the
RG- region of NF90ctv is involved in direct interaction
w i t h  R e v ,  i n  a g r e e m e n t  w i t h  t h e  r e s u l t s  o b t a i n e d  b y
immunoprecipitation of full length NF90ctv (Fig. 3, lane
1).
NF90ctv and Rev show similar subcellular localization
To investigate whether expression of NF90ctv affects the
cellular localization of Rev, we investigated the localiza-
tion of NF90ctv-GFP or of Rev-mRFP in Hela cells 24 h
after transfection with either pNF90ctv/GFP or pGFP/Rev
vectors alone, or after co-transfection with pGFP/NF90 +
Effect of NF90ctv protein domains on the level of expression  of CAT Figure 2
Effect of NF90ctv protein domains on the level of expression 
of CAT. HeLa cells were cotransfected with CAT-RRE, and 
with different constructs that code for Rev protein and the 
NF90ctv domains. After cell lysis, 14C-labelled chlorampheni-
col and acetyl CoA were added to the extracts and the CAT 
activity determined. The construct included in each assay is 
indicated above the lanes. Vertical arrows highlight the con-
structs leading to the strongest decrease in acetylation of 
chloramphenicol. Similar results were obtained in three inde-
pendent experiments. When the cells were transfected only 
with the empty expression vector for NF90 (pCI-neo), 
acetylation of chloramphenicol was not observed (not 
shown).Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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pRev/mRFP (Fig. 5c). In agreement with previous observa-
tions [13], Rev protein alone localized in the nucleus,
mostly in the nucleolus as confirmed by DAPI staining,
and to a lesser extent in the cytoplasm (Fig. 5b). Similar
results were observed when HeLa cells were transfected
with pRev/mRFP (data not shown). NF90ctv alone local-
ized mostly in the nucleus and in the nucleolus (Fig. 5a).
Cells co-transfected with Rev and NF90ctv showed co-
localization of the two proteins in the same cellular com-
partments (Fig. 5c'''), i.e. in the nucleolus and the cyto-
plasm; in this case NF90ctv localized mostly in the
nucleolus and cytoplasm, and to lesser extent in the
nucleus. The results suggest that the subcellular distribu-
tion of NF90ctv is altered in the presence of Rev: both pro-
teins localized in the nucleus and in the cytoplasm.
Interestingly, in the case of HeLa cells co-transfected with
pGFP/NF90 + pRev/mRFP in the presence of LMB, Rev
was concentrated entirely in the nucleolus, whereas NF90
was present both in the nucleus and in the nucleolus (Fig.
5d'–d'''), mostly in the nucleolus.
NF90ctv influences the expression of gene linked to RRE 
structure
To determine whether NF90ctv is directly implicated in
export (and translation) of transcripts linked to RRE, we
used a construct containing the Gag  and  GFP  coding
sequences linked to RRE. In this reporter system as well,
the cytoplasmic translocation and translation of Gag-GFP
protein is Rev-dependent. Furthermore, our results
showed that Rev/GFP retained nuclear/nucleolar localiza-
tion (Fig. 5b), as did NF90ctv which localized in the
nuclear/nucleolar compartment (Fig 5a). As shown (Fig.
6), Gag-GFP mRNA that is linked to RRE, is expressed,
transported to the cytoplasm and translated either in pres-
ence of Rev or the NF90ctv (Fig. 6a' and 6b' respectively).
Rev protein in the presence of RRE, is transported to the
cytoplasm (Fig 6a), where it is tracked with GFP (Fig. 6a").
In presence of NF90ctv (Fig. 6b), Gag-GFP is distributed
throughout the cell (Fig 6b'), however, NF90ctv is mostly
localized in the nucleus/nucleolus (Fig. 6b''), suggesting
that RRE influences localization of NF90ctv. Overall, the
results show that either Rev protein (Rev/mRFP) or
NF90ctv (NF90/mRFP) influence Gag-RRE-GFP expres-
sion, suggesting that NF90ctv may influence the nucleocy-
toplasmic translocation of RRE containing transcripts,
analogous to Rev function. The results shown in figure 6
were observed in 4 independent experiments.
Discussion
The space of interactions between viral and host elements
is complex, and our understanding of these dynamics is
incomplete. In this study we explored whether the
NF90ctv-mediated inhibition of HIV-1 Rev involved Rev-
NF90ctv interaction. The results presented here show that
NF90ctv inhibits the Rev mediated export of viral RNA. To
refine this observation, and study its molecular mecha-
nisms, we created a series of vectors containing segments
of the NF90ctv gene to use in transfection studies. We
investigated the possibility that specific regions of
NF90ctv may be involved in blocking Rev-mediated RNA
export activity, by expressing the NF90ctv regions in HeLa
cells. Three regions of NF90ctv in particular diminished
Rev function, the NES, DRBD 2 and the C-terminal RG-.
The region of NF90ctv with the greatest inhibition of Rev
function, the RG- domain, consists of the C-terminal 67
amino acids. This domain contains three SH3 motifs that
are rich in Pro, which has been described to be involved
in protein:protein interactions [31]. SH3 motifs are highly
conserved and are present in many proteins that interact
Immunoprecipitation Figure 3
Immunoprecipitation. HeLa cells were cotransfected with 
pRSV/Rev and pOZ-Flag/NF90; 24 h post-transfection, the 
cells were lysed, α-Flag antibodies were added and the pro-
teins precipitated by adding protein A agarose. The samples 
were analyzed by SDS-PAGE, and the proteins transferred to 
a PVDF membrane were immunodetected using α-Rev31–50 
antibodies. Lane 1, extracts from HeLa cells cotransfected 
with both constructs. Lane 2, extracts from untransfected 
HeLa cells. Lane 3, same amount of HeLa cell extract prior to 
immunoprecipitation (input control). Arrow indicates the 
protein band (~28 kDa) corresponding to Rev.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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with RNAs. We suggest that the SH3 motifs of NF90ctv
may be involved in the Rev:NF90ctv interaction to block
Rev function.
In addition, studies have indicated that NF90 possesses
several regions capable of protein:protein interactions;
including PKR [32,33], NF45 [16], and eIF-2 [26]. Protein
motifs capable of interacting with dsRNAs can also partic-
ipate in protein:protein interactions, such as homodimer-
ization, as in the case of Rev. The active homodimers of
Rev protein form complexes with the RRE structure
[34,35]. Proteins with dsRNA binding motifs can also
interact with dsRNA ligands bound to proteins implicated
in innate immunity and defence against viral infections,
such as PKR [36,37]. The detailed elucidation these inter-
actions will be required to understand the dynamics of
viral – host interactions.
The NES region of NF90ctv used in this study comprises
amino acids 81–190 that include a Leu-rich sequence,
present in the different NF90 isoforms encoded by the ifl-
3 gene [14]. This region contains the LX3LX3LXL sequence,
similar to the consensus LX2–3LX2–3LXL reported to be
part of the NES in Rev [38]. The NES domain of NF90ctv
has been suggested to play an important role in the shut-
tling of the protein between the nucleus and the cyto-
plasm that is required for IL-2 mRNA translocation and
stabilization [24]. Both Rev export [7] and NF90ctv export
are LMB-sensitive. Since the NES motif located in the N-
terminal region of NF90ctv is similar to the hydrophobic
Leu-rich region present in proteins [24] known to recruit
the exportin Crm1 [3], we suggest that export of NF90ctv
to the cytoplasm may be Crm1-dependent (Fig. 7b). This
is supported by the observation that in cells treated with
leptomycin B (Fig. 5d) NF90ctv is restricted in the nucleus
(mostly in the nucleolus), suggesting that Crm1 recog-
nizes the NES domain of NF90ctv. Following cell activa-
tion with 12-O-tetradecanoyl phorbol-beta-acetate and
calcium ionophore A23187, a major portion of GFP/
NF90 was translocated to the cytoplasm, and this translo-
cation was inhibited by pretreatment with LMB. When
NF90ctv is overexpressed in presence of the Gag gene
linked to RRE, the Gag-RRE transcript is translocated to
the cytoplasm (Fig. 6). We propose that competition
between NF90ctv and Rev for Crm1 binding is a possible
mechanism of interference with Rev function and that the
interaction between NF90ctv and Rev influences the affin-
ity of viral protein for RRE RNA structure (Fig. 7d).
However, since NF90ctv contains two dsRNA binding
motifs, a direct interaction between NF90ctv and the HIV-
1 RRE RNA structure may be equally important in block-
ing Rev function. These two DRBDs bind to the small and
highly structured human Adenovirus transcript desig-
nated Adeno-associated virus RNA [18], to the highly con-
served encapsidation signal ε of the Hepatitis B
pregenomic RNA [19], and also to the 3' UTR of Tau
mRNA [25]. We investigated whether NF90ctv could bind
the RRE structure. Our results suggest that NF90ctv is able
to bind to RRE, leading to the expression of the protein
coding sequence linked to the RRE-RNA structure. Our
results suggest that interaction between NF90ctv and Rev
protein (Fig 7c), as well as direct interaction between
NF90ctv and RRE RNA structure may affect RNA export
from the nucleus (Fig. 7b). We suggest that competition
between NF90ctv and Rev for RRE binding could in part
explain the decrease of Gag expression. However, the
overall molecular mechanisms of NF90ctv mediated anti-
viral response will require further studies.
Rev protein has been reported to reside mainly in the
nucleus [2], and is translocated to cytoplasm in presence
of RRE (Fig. 6a and Fig. 7a). Rev shuttles between the
Interaction between the NF90ctv RG- domain and Rev by  affinity chromatography Figure 4
Interaction between the NF90ctv RG- domain and Rev by 
affinity chromatography. (A) The GST/RG- recombinant pro-
tein was expressed in E. coli, the cell extracts coupled to a 
glutathione-Sepharose 4B column was used in pull-down 
assays with HeLa cell extracts previously transfected with 
pRSV/Rev (lane 4) or the control lysate (lane 3). A protein 
band corresponding to Rev (arrowhead, lane 4) was detected 
when extracts from HeLa cells that expressed Rev were 
added to the GST/RG- protein bound column; such a band 
was absent from control HeLa cell extract (lane 3). Lane 1, 
GST/RG- purified from E. coli induced by IPTG, and lane 2, 
purified from non induced E. coli cells. (B) Similar assays per-
formed with purified Rev protein from E. coli in place of HeLa 
cells extracts. Arrow in lane 5 indicates the position of Rev. 
This band was not observed in absence of Rev (lane 6).Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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nucleus and cytoplasm, since it harbours the NLS domain
that interacts with Importin β. The NES domain of Rev is
recognized by Crm1/exportin 1 [39]. Substitution of Rev
and RRE by an export promoting sequence construct, RTE
m26 – CTE, produces infectious virus [40], suggesting that
export is indeed a primary function of Rev:RRE. Similar to
Rev, NF90 has been described mainly in the nucleus yet,
it can shuttle between the nucleus and the cytoplasm due
to its NES and NLS motifs [24]. When NF90ctv is
expressed in presence of RRE RNA structure (GFP-RRE), it
is tethered in the nucleus, whereas mRNA linked to RRE
would normally be exported to the cytoplasm.
Overall, the results are consistent with a mechanism of
inhibition of Rev based on the interaction of Rev protein
with specific domains of NF90ctv. The Rev-NF90ctv inter-
Subcellular localization of the Rev and NF90ctv proteins observed by fluorescence microscopy in confocal optical sections Figure 5
Subcellular localization of the Rev and NF90ctv proteins observed by fluorescence microscopy in confocal optical sections. 
HeLa cells were transfected with pGFP/NF90 or pGFP/Rev and GFP was visualized with an Argon laser at 488 nm. NF90 local-
ized in the nucleus and nucleolus; Rev localized in the nucleus, nucleolus and cytoplasm (panels a and b). To study the effect of 
NF90ctv on Rev localization, HeLa cells were cotransfected with both expression vectors and the proteins were observed in 
confocal optical sections; the mRFP was visualized using a Krypton laser at 568 nm. Both protein colocalized in the similar sub-
cellular compartments (c'-c''; d'-d'' are the same as c'-c'''). In the presence of 50 ng/ml of LMB and both proteins localized mostly 
in the nucleolus. Bar = 5 μm.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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action may prevent Rev homodimer formation, an essen-
tial step in interaction of Rev with RRE. For the export of
unspliced or incompletely spliced transcripts to be effi-
cient, Rev must be imported back into the nucleus where
it must reach a specific concentration [2] to induce com-
plex formation with the RRE. The transdominant Rev
mutant, RevM10, that inhibits Rev activity [41], is
restricted to the nucleus and competes with Rev for inter-
action with the RRE. Rev-dependent export has been
reported to be specifically inhibited by LMB [42] which
prevents the interaction between Rev and Crm1. Likewise
Sam68ΔC, (i.e. the cell protein Sam68 devoid of its C-ter-
minal domain), inhibits Rev activity, thereby preventing
the transcripts from entering the translation machinery
[43]. The authors conclude that Sam68ΔC leads to perinu-
clear accumulation of the unspliced or incompletely
spliced mRNAs of HIV-1.
The results described here suggest a novel means of inhi-
bition of HIV-1 Rev function based on direct interaction
between NF90ctv and Rev, interfering with the export
activity of Rev (Fig. 7). To our knowledge, no cellular pro-
tein has to date been reported to have such an effect. The
antiretroviral compounds presently in use may be of lim-
ited use due to emerging drug resistant viral strains.
Results described here open the possibility of exploring
novel therapeutic approaches against HIV-1/AIDS, based
on NF90-mediated inhibition of Rev.
Methods
Constructs and plasmids
The pEFX90 vector harboring the entire human NF90 cod-
ing sequence was kindly provided by P. N. Kao (Stanford
Univ., Calif.). To produce Flag/NF90, the NF90 coding
sequence was recovered from pEFX90 by NcoI digestion
and subcloned into the pUC18 vector upstream of and in-
frame with the Flag-coding sequence. The Flag/NF90 cod-
ing sequence was then excised by NsiI and MscI digestion
and ligated into the pOZ vector kindly provided by Dr. B.
Howard (NIH) and previously cleaved by XhoI and NsiI,
yielding the pOZ-Flag/NF90.
The pCI-neo/NF90 construct that allows expression of
NF90ctv was described previously [22]. The NF90N-ter-
minal and NF90C-terminal coding sequences were recov-
ered from pCI-neo/NF90 by NheI/XbaI and XbaI/NotI
digestion respectively and cloned into pCI-neo vector
cleaved with the same enzymes, producing pCI-neo/N-ter
NF90ctv and pCI-neo/C-ter NF90ctv respectively. To
express other regions of NF90ctv proteins (NES, DRBD 1,
DRBD 2, RG-; Fig. 1C) the appropriate regions of cDNA
were amplified from pCI-neo/NF90 by PCR using specific
primers (Table 1) and after EcoRI/SmaI digestion the prod-
ucts were inserted into pCI-neo using the same restriction
enzymes.
The pcsRev/GFP was kindly provided by Dr. George Pav-
lakis (National Cancer Institute, Frederick, Md). The
reporter plasmid pCMV128 (provided by Dr. Thomas J.
Hope, Northwestern University, Chicago) carries the sec-
ond intron of HIV-1 with the RRE structure downstream
of the CAT coding sequence (Fig. 1A) and therefore the
expression of CAT strictly depends on Rev:RRE interaction
for export of the CAT coding sequence [13]. pRSV/Rev that
expresses Rev was kindly provided by Dr. T. J. Hope; the
pSGT-5(SDM/RRE/CM-GFP) was kindly provided by Dr.
S. Arya (NCI/NIH) and contains the HIV-1 Gag gene and
the GFP gene linked to HIV RRE structure. The GFP-cod-
ing pEGFP-N1 was from Clontech.
To obtain the pRev/mRFP construct that expresses the
monomeric red fluorescent protein (mRFP), the following
strategy was used. The mRFP cassette was amplified from
pcDNA3 (kindly provided by R. Y. Tsien, University of
California, San Diego) using the 5'primer GGATCCGCG-
GCAGACCATGGCTAGCA and the 3'primer GCG-
NF90ctv affects structured-RNA translocation Figure 6
NF90ctv affects structured-RNA translocation. HeLa cells 
were cotransfected with pRev/mRFP and pSGT-5(SDM/RRE/
CM-GFP) or with pNF90/mRFP and pSGT-5(SDM/RRE/CM-
GFP). The constructs represent HIV-1 Gag and GFP genes 
linked to RRE, making their expression dependent on Rev. 
The reporter gene (GFP) linked to RRE is expressed either in 
presence of Rev or NF90ctv (a and b, respectively). As con-
trols HeLa cells were transfected with each construct alone. 
In presence the RRE, Rev localized mainly in the cytoplasm 
(a), colocalized with the GFP reporter (a''). However, 
NF90ctv in the presence of RRE, preferentially localized in 
the nucleus/nucleoli (b), and GFP reporter was distributed in 
the cytoplasm and in the nucleus.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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Table 1: Primers used to amplify regions of NF90ctv by PCR for cloning into the pCI-neo vector.
Amplified region Construct
5'-primer: 5'GGGGGGGAATTCGCTAGCCGCCACCAATGCAGAAGACGGAGCACATGAC3'
3'-primer: 5'GGGGGGCCCGGGGCGGCCGACTAGATGGTCAGGGACAATGGACGCTCTTT3'
NES pCI-neo/NES NF90
5'-primer: 5'GGGGGGGAATTCGCTAGCCGCCACCAATGAATGCCCTGATGCGGTTGAA3'
3'-primer: 5'GGGGGGCCCGGGGCGGCCGACTAAGCACCCGTCGGCAAGCCCATGTCCTG3'
DRBD 1 pCI-neo/DRBD 1 NF90
5'-primer: 5'GGGGGGGAATTCGCTAGCCGCCACCAATGAAGAACCCAGTCATGGAGCTG3'
3-primer: 5'GGGGGGCCCGGGGCGGCCGACTAAGGGAAAAGTTTTTCTAGGGCAGCAAG3'
DRBD 2 pCI-neo/DRBD 2 NF90
5'-primer: 5'GGGGGGGTCGACCGCCACCAATGAAGCTTTTCCCTGACACCCCTCTCGCC3'
3'-primer: 5'GGGGGGCCCGGGCGGCCGCCTATGTAGCCTCCATGGTTGGCGCCACCAAA3'
RG- pCI-neo/RG- NF90
Model for regulation of Rev protein by NF90 Figure 7
Model for regulation of Rev protein by NF90. The HeLa cells are cotransfected with the respective plasmids. In (a), the tran-
script of the gene linked to RRE is recognized by Rev and forms a complex with CRM1, it is exported to the cytoplasm, where 
it is translated by the ribosome. In (b) based on the data presented herein, we suggest that NF90 is able to recognize the tran-
script of the gene linked to RRE, and then it is exported to the cytoplasm and translated. In (c) we suggest that this process is 
CRM1-dependent. Because our immunoprecipitation results show that NF90 interacts with Rev and their colocalization in the 
cytoplasm is CRM1-dependent, In (d) we propose that the affinity of Rev or NF90 for RRE, is affected by protein-protein inter-
action (NF90-Rev), with as a consequence low expression of the gene linked to RRE; another possibility would be that the 
interaction of NF90 with Rev, alters the conformation of Rev, allowing decreased access to RRE.Retrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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GCCGCTTAGGCGCCGGTGGAGTG. The 5'primer
presents a BamHI site (underlined) and a Kozak sequence,
and the 3'primer a NotI site (underlined). On the other
hand, pEGF-N1, which expresses the GFP, was cleaved
with BamHI and NotI to delete the EGFP cassette, and
replaced it by the mRFP PCR product to obtain the pmRFP
construct used to transform Escherichia coli DH5α. Rev
was amplified from pRSV/Rev using the 5'primer GAAT-
TCTGCCGCCACCATGGCAGGAAGAAGCGGA (EcoRI
underlined) and the 3'primer CCCGGGTTCTTTAGCTC-
CTGACTCCAA (SmaI underlined). The PCR product was
digested with EcoRI/SmaI and ligated into pmRFP previ-
ously digested with the same enzymes to obtain the pRev/
mRFP construct.
To introduce the RG- region of NF90ctv (Fig. 1C) into
pGEX-4T-3 (Amershan), the corresponding region was
released from pCI-neo/RG- NF90 using EcoRI/SmaI and
cloned into pGEX-4T-3, yielding pGST/RG- that codes for
the GST/RG- protein.
Cell culture and transfection
A human osteosarcoma cell line stably transduced with
CD4 and CXCR4, a T-tropic HIV-1 target cell line
(GHOST/CD4+/CXCR4+), was maintained as described
[22] except that fetal bovine serum was from Invitrogen,
or from Vecol, Colombia. Cells were plated at ~3 × 105
cells per 35 mm-diameter dish 24 h before transfection
with 2 μg each of the appropriate plasmid DNA using
Superfect (Qiagen) following the manufacturer's instruc-
tions. Cells were harvested 24 or 48 h after transfection
and lysed as described [13]. The protein concentration of
lysates was determined by the Bradford assay (Bio-Rad).
To evaluate expression of Rev and Flag/NF90 following
co-transfection with pRSV/Rev and pOZ-Flag/NF90, cell
extracts were analyzed by SDS-PAGE, the proteins trans-
ferred to a polyvinylidene-difluoride membrane (PVDF;
Bio-Rad), and immunodetected with α-Rev31–50  or  α-
Rev71–90 antibodies (generously supplied by S. Marques,
George Washington University), or α-Flag antibodies
(Sigma).
CAT assay
HeLa cells were co-transfected with the plasmid constructs
outlined in Table 1. To normalize transfection efficiency,
the pEGFP-N1 control plasmid was included in each
transfection assay. Cell lysates containing equal amounts
of protein were used in the CAT assays performed as pre-
viously described [13]. The results are presented as fold
increase or decrease in CAT activity measured as chloram-
phenicol acetylation normalized proteins from cells trans-
fected with the pCMV128 reporter plasmid alone or the
pCI-neo empty expression vector for NF90 as negative
control.
Immunoprecipitation and immunoblot analysis
For the immunoprecipitation assays, 4 × 105 HeLa cells
were grown to about 80% confluence and cotransfected
with 1.5 μg each of pRSV/Rev and pOZ-Flag/NF90, and
after 24 h extracts were prepared as described above. Cell
extracts (35 μl) were preincubated overnight at 4°C with
5 μl of α-Flag antibodies with gentle shaking. Protein A
agarose (10 μl; Invitrogen) was then added and incuba-
tion continued for 3 h. The precipitate was recovered by
centrifugation, washed 3 times in PBS 1× and the resin
suspended in 20 μl of 4 × Laemmli buffer. The protein sus-
pension was analyzed by SDS-PAGE, transferred to a
PVDF membrane and probed using α-Rev31–50 antibodies.
The same amount of HeLa cell extract prior to immuno-
precipitation was used as input control in western blot
assays.
Expression and purification of the recombinant GST/RG- 
protein in E. coli
E. coli XL1 Blue cells transformed with pGST/RG- were
induced or not overnight with 0.5 mM IPTG and lysed
using lysis buffer (50 mM Tris-Cl pH 8.0, 1 mM EDTA,
100 mM NaCl and 1 mg/ml of lysozyme). The recom-
binant protein was purified using a glutathione-Sepharose
4B column (MicroSpin™ GST Purification Module, Amer-
sham) following the manufacturer's instructions. The
recombinant protein was verified by SDS-PAGE and by
immunoblotting with α-GST (Amersham) or α-GST/RG-
polyclonal antibodies.
Determination of NF90 RG-/Rev interaction by affinity 
chromatography
After binding the GST/RG- protein to the glutathione-
Sepharose 4B column, extracts from 106 HeLa cells trans-
fected with pRSV/Rev, or 15 μg of purified Rev protein
[44] [obtained through the AIDS Research and Reference
Reagent Program, Division of AIDS, and NIAID, NIH:
HIV-1 (wild type) from D. Rekosh, M.-L. Hammarskjöld,
and M. Orsini] were added to the column. After several
washes to remove unbound protein, the GST/RG-:Rev
protein complex was eluted and analyzed by SDS-PAGE
and the proteins detected by Coomassie staining.
Cell localization
To determine if NF90ctv influences the cellular localiza-
tion of Rev, HeLa cells (8 × 104) were co-transfected either
with 1 μ pRev/mRFP alone, with 1 μ pRev/mRFP + 1 μ
pGFP/NF90 or with 1 μ pGFP/NF90 alone; 1 μ pmRFP
was used as negative control. After 24 h, the cells were
fixed for 20 min with 2% paraformaldehyde at room tem-
perature. Following three washes with 1 × PBS, the nuclei
were stained with 4-6-diamidino-2-phenylindol (DAPI),
the cells were mounted with Citifluor (Canterbury, UK)
and the GFP or mRFP was detected using a Leica SP2
AOBS confocal microscope with a 63×, 1.32NA PlanApoRetrovirology 2006, 3:83 http://www.retrovirology.com/content/3/1/83
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lens using an Argon laser (488 nm) or a Krypton laser
(568 nm), respectively. The images were assembled using
Adobe PhotoShop.
To study the effect of leptomycin B (LMB) on the subcel-
lular localization of Rev and NF90ctv, HeLa cells were co-
transfected as described above, and 24 h later, 50 ng/ml of
LMB were added and incubation continued for 2 h at
37°C in 5% CO2. The cells were then fixed following the
procedure described above and observed using a Leica SP2
AOBS confocal microscope.
RRE-binding study
To examine if NF90 is able to bind the RRE RNA, the HeLa
cells were transfected with either 1 μ pRev/mRFP alone or
with 0.4 μ pSGT-5(SDM/RRE/CM-GFP) or with 1 μ
pNF90/mRFP with or without 0.4 μ pSGT-5(SDM/RRE/
CM-GFP). As negative control, we used the HeLa cells tras-
nfected only with pSGT-5(SDM/RRE/CM-GFP). After 24
h, the GFP or mRFP was detected by confocal microscopy,
as described above.
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